| Basic Materials | 0.00% | |
|---|---|---|
| Consumer Cyclical | 0.00% | |
| Financial Services | 0.00% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 0.00% | |
| Healthcare | 91.64% |
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 40.32 | 0.14 (+0.35%) | 28.51 - 40.73 | 104.5 thousand (Below Avg) |
Market data as of 4:00PM 05/17/13. Quotes are delayed by at least 15 min.
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant(R) Health Care Index. The fund will normally invest at least 90% of its net assets in common stocks that comprise the index. The index is a modified equal-dollar weighted index designed by NYSE Euronext to objectively identify and select stocks from the Russell 1000(R) Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX(R) selection methodology. It is non-diversified.
| Open | 40.20 |
|---|---|
| Previous Close | 40.18 |
| Day's Range | 40.09 - 40.32 |
| Avg Volume (10 Day) | 139.1K |
| Total Assets | $835.03M |
| Expense Ratio | 0.73% |
| Yield (Trailing 12 Mo.) | 0.36% |
| Fund Inception | 05/08/2007 |
| Timeframe | FXH | S&P 500 | Health |
|---|---|---|---|
| 1 Month | 2.33% | 1.93% | 3.38% |
| 3 Month | 9.92% | 7.18% | 10.04% |
| Year-to-Date | 19.66% | 12.74% | 17.90% |
| 1 Year | 26.29% | 16.89% | 26.16% |
| 3 Year | 18.35% | 12.80% | 17.80% |
| 5 Year | 16.21% | 5.21% | 13.29% |
| 10 Year | -- | 7.88% | 8.84% |
| Since Inception | 11.95% | 10.38% | -- |
| Basic Materials | 0.00% | |
|---|---|---|
| Consumer Cyclical | 0.00% | |
| Financial Services | 0.00% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 0.00% | |
| Healthcare | 91.64% |
| Utilities | 0.00% | |
|---|---|---|
| Communication Services | 0.00% | |
| Energy | 0.00% | |
| Industrials | 0.00% | |
| Technology | 8.36% |
| Valuation | FXH | Category Range |
|---|---|---|
| Price/Earnings | 18.71 | |
| Price/Book | 2.49 | |
| Price/Sales | 0.88 | |
| Price/Cash Flow | 10.71 | |
| Dividend Yield | 0.79 | |
| LT Earnings | 11.77 | |
| Historical Earnings | 10.27 | |
| Sales Growth | 10.64 | |
| Cash-Flow Growth | 6.75 | |
| Book-Value Growth | 11.26 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
![]() | ![]() | ![]() |

| Rating | vs Category | |
|---|---|---|
| Overall | ![]() ![]() ![]() | |
| Risk | Avg | |
| Return | Avg |
| Beta | 0.70 |
|---|---|
| Standard Deviation | 14.61 |
| Alpha | 10.60 |
| Sharpe Ratio | 1.22 |
| Mean | 19.56 |
| R-Squared | 63.65 |
| Pretax Return | 18.35% |
|---|---|
| Tax-adjusted Return | 18.26% |
| Tax Cost Ratio | 0.08% |
| Potential Cap Gains | 17.68% |